Form 8-K - Current report:
SEC Accession No. 0001615774-17-000848
Filing Date
2017-03-01
Accepted
2017-03-01 16:34:06
Documents
2
Period of Report
2017-03-01
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K s105445_8k.htm 8-K 15619
2 EXHIBIT 99.1 s105445_ex99-1.htm EX-99.1 103619
  Complete submission text file 0001615774-17-000848.txt   120564
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

EIN.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-24006 | Film No.: 17654654
SIC: 2834 Pharmaceutical Preparations